Toggle navigation
Home
Search
Services
Blog
Contact
About
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
Fox Chase Cancer Center (INC)
Search grants from Fox Chase Cancer Center (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Loss of Mitochondrial Sirt3, Decreased MnSOD Activity, and IR Induced Genomic Instability
Planning the Framework Program for Global Health
Development of Immunoassays for P450 Eicosanoids
Minority High School Student Research Apprentice Program
Minority High School Student Research Apprentice Program
Recently added grants:
Regulation of hippocampal morphogenesis and homeostasis by the E3 ubiquitin ligase CRL5
Leadership Administrative Core
Career Enhancement Core
Resource Support Core
Impact of Sex on Prenatal Stress-Immune Programming of Depression and Autonomic Dysregulation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025011-000
Application #
6688657
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
NIH 2002
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
Comments
Be the first to comment on this grant